Feb 08 2022

Investing in Health Tech and Precision Medicine Real Asset Live

Presentation and TV Reports From Feb 08 2022

All presentations All videos

Laboratory boosts Glasgow’s life science infrastructure: Carol Clugston, Dean of Corporate Engagement & Innovation, University of Glasgow

Carol Clugston, Director,...

Precision medicine’s data needs could trap landlords: James Sheppard, Head of Commercial UK & Ireland, Kadans Science Partner

James Sheppard, Head of...

Networking and size attract life science innovators to Scotland: Marian McNeil, CEO, Precision Medicine Scotland Innovation Centre

Marian McNeil, CEO Precision...

Access to clinical expertise vital for life science firm BioClavis: Harper VanSteenhouse, President, BioClavis

Harper VanSteenhouse,...

Scottish government pushing “hugely important” life sciences: Ivan McKee MSP, Minister for Trade, Investment and Innovation, Scottish Government

Ivan McKee MSP, Minister for...

Investing in Health Tech & Precision Medicine – Living Laboratory Presentation (slides)

Carol Clugston, Director,...

Investing in Health Tech and Precision Medicine – ON DEMAND – Full Event, February 2022

Investing in Health Tech & Precision Medicine – Living Laboratory Presentation – ON DEMAND

Carol Clugston, Director,...

Investing in Health Tech & Precision Medicine – ON DEMAND – Panel, Feb 2022

Speaking at this event

Minister for Trade, Investment and Innovation Scottish Government, Scotland

Director, Living Laboratory for Precision Medicine University of Glasgow,...

CEO Precision Medicine Scotland Innovation Centre, United Kingdom

Head of Commercial UK & Ireland Kadans Science Partner, The Netherlands

Harper VanSteenhouse

President BioClavis, United Kingdom

Partner, Department Head, National Offices Knight Frank, United Kingdom

Upcoming events

Jun 13

Social Impact Strategies: creating user-centred, ESG outperformance

Jun 22

The CEE Summit, 9th edition

Jun 27

The Senior Housing & Healthcare Summit

Jun 28

Why Iberia?